ArticleFrontiers in medicine2026

Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case report.

Jose Miguel Torregrosa Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.